BioCryst Pharmaceuticals, Inc.

NASDAQ:BCRX

Biotechnology

Healthcare
$7.32 +1.02%

+$0.09 today

Market cap
$1.88B
Beta
0.56
P/E (TTM)
-4.8
EPS (TTM)
-$1.89
52W Low $6.00High $10.32

Volume 3.78M

Average 4.85M

Balance Sheet

Inspect the capital base behind the business.

Assets

$514.16M

FY 2025 · Annual

+4.8% YoY

Liabilities

$633.31M

FY 2025 · Annual

-34.5% YoY

Equity

-$119.15M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents504.39M304.77M110.64M104.92M89.74M
Short-term Investments3.21M119.54M278.34M216.14M185.01M
Net Receivables29.41M50.6M56.95M79.07M106.82M
Inventory15.79M27.53M28.68M8.09M5.4M
Other Current Assets3.35M14.06M21.35M13.75M17.38M
Total Current Assets566.14M516.5M495.97M421.97M404.35M
Property, Plant & Equipment (Net)15.19M8.62M20.91M19.79M18.99M
Goodwill00000
Intangible Assets00000
Long-term Investments6.83M18.08M021.72M61.16M
Tax Assets00000
Other Non-current Assets06.81M80K26.94M29.66M
Total Non-current Assets22.02M33.5M20.99M68.45M109.81M
Total Assets588.15M550M516.96M490.42M514.16M
Account Payables27.81M14.36M20.89M11.64M15.83M
Short-term Debt00035.45M0
Tax Payables2.62M410K000
Deferred Revenue1.42M1.22M000
Other Current Liabilities52M36.46M86.59M64.66M129.69M
Total Current Liabilities103.72M105.51M149.99M160.38M196.07M
Long-term Debt585.46M733.28M811.27M795.92M427.23M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities591.42M739.08M822.5M805.97M437.25M
Total Liabilities695.14M844.6M972.49M966.35M633.31M
Common Stock1.84M1.88M2.06M2.09M2.13M
Retained Earnings(1.21B)(1.45B)(1.68B)(1.77B)(1.51B)
Accumulated OCI177K26K1.34M921K38K
Other Stockholders Equity00000
Minority Interest00000
Total Equity(106.99M)(294.6M)(455.53M)(475.93M)(119.15M)
Total Debt593.24M741.45M825.15M841.42M438.87M
Net Debt88.85M436.69M714.51M736.5M349.14M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$155.0M
Short-term Investments$197.6M
Receivables$110.8M
Inventory$6.1M
Other Current$15.3M
Total Current Assets$484.7M
PP&E (Net)$21.7M
Other Non-current$51.5M
Total Non-current Assets$73.2M
Total Assets$557.9M

Analysis

Selected assets total $557.9M for Latest. The largest visible component is Short-term Investments at $197.6M, about 35.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipSep 2, 2026
4Statement of changes in beneficial ownershipSep 2, 2026

How much cash does BCRX have?

BioCryst Pharmaceuticals, Inc. (BCRX) reported $89.74M in cash and equivalents in fiscal 2025.

How much debt does BCRX carry?

BioCryst Pharmaceuticals, Inc. (BCRX) reported $438.87M of total debt, with net debt of $349.14M.